Oncogenes

Feb 22, 2018

Benitec Biopharma reports financial results for the 2018 fiscal second quarter and provides operational update

Jan 18, 2018

QIAGEN Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer

Dec 21, 2017

MEI Pharma Announces Study of Clinical Stage Oral CDK Inhibitor Voruciclib Published in Nature Scientific Reports

Nov 15, 2017

Ascentage Pharma Announces U.S. FDA Acceptance of IND Application for Clinical Study of Novel IAP Inhibitor APG-1387 to Treat Advanced Solid Tumors and Blood Cancers

Nov 06, 2017

FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer

Jun 21, 2017

Avant Diagnostics Appoints Philippe Goix, PhD, MBA as President & CEO to Commercialize Proprietary Theralink® Tumor Biomarker Platform

Jun 06, 2017

Exploratory Analysis of the Phase I/II CHRYSALIS Study of gilteritinib Demonstrates First Molecular Response to FLT3 Inhibitor in Acute Myeloid Leukemia